康讯生物分析有限公司:以研究带来影响 Health View Bioanalytic Limited: Generating Impact from Research (Simplified Chinese version)
Pong Yuen Howard Lam, Hugh Thomas, Elsie Tsui, Shi Yu LU
Product #:W34027
Supplier:Ivey/CUHK
Discipline:Entrepreneurship, Marketing
Setting:Hong Kong, 2021
Industries:
Geography:
Your Price:$10.54
Purchase this material with a free Educator Account and enjoy more benefits:
- Free Educator Copy
- Free Teaching Notes
- Build your coursepack
- Discounted academic price
Learning Objectives
- 评估企业对企业关系,提供以客户为中心的健康服务。
- 了解将技术转化为实用的应用程序来为客户创造价值的重要性。
- 理解人工智能在诊断中的用途。
- 了解社会企业与营利性企业的共性和差异。
- 分析社会企业环境中“富人与国王”的权衡。
- 考虑扩大规模的备选方案,包括定位为社会企业与营利性企业、出售公司、寻求不同的社会融资模式、特许经营、寻求分销权,以及寻求合作伙伴关系。
This case can be used in senior undergraduate- and graduate-level courses on for-profit and social entrepreneurship. Students should have taken basic business courses—accounting, finance, management, marketing—and be familiar with analyzing the business model of a start-up. The major objective of the case is to allow students to analyze alternative models for delivering innovative health risk assessments. The case provides an example of how artificial intelligence is impacting the health care industry. It allows students to consider social entrepreneurship versus for-profit entrepreneurship, and adds another dimension to the “rich versus king” dilemma. After working through the case and assignment questions, students will be able to do the following:
- Assess business-to-business relationships for a customer-centric health service.
- Understand the importance of turning technology into useful applications to create value for customers.
- Appreciate one use of AI in diagnostics.
- Understand the commonalities and differences between social enterprises and for-profit enterprises.
- Analyze the “rich versus king” trade-off in a social enterprise setting.
- Consider the alternatives for scaling up, including positioning as social enterprise versus for-profit venture, selling the company, seeking different social financing models, franchising, pursuing distributorships, and pursuing partnerships.